In breast cancer cell lines, Mittendorf et al showed that PTEN loss resulted in overexpression of PD‐1 and PD‐L1 which was downregulated after PI3K pathway inhibition and may increase antitumor adaptive processes.41 This evidence concerns the gene PIK3CA and breast carcinoma.